Phase I study to evaluate toxicity and feasibility of intratumoral injection of alpha-gal glycolipids in patients with advanced melanoma.
Mark R. Albertini
Research Funding - Agalimmune
Erik Ranheim
No relevant relationships to disclose
Cindy Zuleger
Research Funding - Agalimmune
Paul M. Sondel
No relevant relationships to disclose
Jacquelyn A Hank
No relevant relationships to disclose
Alan Bridges
No relevant relationships to disclose
Michael Newton
No relevant relationships to disclose
Thomas McFarland
No relevant relationships to disclose
Jennifer Collins
No relevant relationships to disclose
Erin Clements
No relevant relationships to disclose
MaryBeth Henry
No relevant relationships to disclose
Heather B. Neuman
No relevant relationships to disclose
Sharon M. Weber
No relevant relationships to disclose
Giles Francis Whalen
No relevant relationships to disclose
Uri Galili
Consultant or Advisory Role - Agalimmune
Stock Ownership - Agalimmune
Research Funding - Agalimmune
Other Remuneration - Agalimmune